Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bethany C Prudner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neuro-Oncology Advances|July 10, 2020
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectivesBethany C Prudner, Tyler Ball, Richa Rathore, et al.
Biochemistry|November 2, 2010
p67/MetAP2 suppresses K-RasV12-mediated transformation of NIH3T3 mouse fibroblasts in culture and in athymic miceAvijit Majumdar, Arnab Ghosh, Samit Datta, et al.
FEBS Letters|December 3, 2014
α-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titinBethany C Prudner, Pritam Sinha Roy, Derek S Damron, et al.
Pharmacology Research & Perspectives|July 15, 2015
Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCεPritam Sinharoy, Hongyu Zhang, Sayantani Sinha, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2016
Liposarcoma: molecular targets and therapeutic implicationsKate Lynn J Bill, Lucia Casadei, Bethany C Prudner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2019
Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative TumorsBethany C Prudner, Richa Rathore, Anthony M Robinson, et al.
Cell Death & Disease|May 2, 2024
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stressRony Takchi, Bethany C Prudner, Qingqing Gong, et al.
Integrative Cancer Therapies|November 22, 2022
Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast CancerSamantha K Greaney, Neha Amin, Bethany C Prudner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neuro-Oncology Advances|July 10, 2020
Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectivesBethany C Prudner, Tyler Ball, Richa Rathore, et al.
Biochemistry|November 2, 2010
p67/MetAP2 suppresses K-RasV12-mediated transformation of NIH3T3 mouse fibroblasts in culture and in athymic miceAvijit Majumdar, Arnab Ghosh, Samit Datta, et al.
FEBS Letters|December 3, 2014
α-Synemin localizes to the M-band of the sarcomere through interaction with the M10 region of titinBethany C Prudner, Pritam Sinha Roy, Derek S Damron, et al.
Pharmacology Research & Perspectives|July 15, 2015
Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCεPritam Sinharoy, Hongyu Zhang, Sayantani Sinha, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2016
Liposarcoma: molecular targets and therapeutic implicationsKate Lynn J Bill, Lucia Casadei, Bethany C Prudner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2019
Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative TumorsBethany C Prudner, Richa Rathore, Anthony M Robinson, et al.
Cell Death & Disease|May 2, 2024
Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stressRony Takchi, Bethany C Prudner, Qingqing Gong, et al.
Integrative Cancer Therapies|November 22, 2022
Yoga Therapy During Chemotherapy for Early-Stage and Locally Advanced Breast CancerSamantha K Greaney, Neha Amin, Bethany C Prudner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2015
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated LiposarcomaKate Lynn J Bill, Jeannine Garnett, Isabelle Meaux, et al.
Cancer Cell International|July 10, 2018
miR-133a function in the pathogenesis of dedifferentiated liposarcomaPeter Y Yu, Gonzalo Lopez, Danielle Braggio, et al.
Pageof 2